Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN): Reassessing Prospects
Sonnet BioTherapeutics Holdings Inc (SONN) concluded trading on Thursday ata closing price of $0.81, with 2.47 million shares of worth about $2.0 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -48.08% during that period and on August 15, 2024 the price saw a […]
